Alterity Therapeutics (ATHE) Change in Accured Expenses (2015 - 2020)

Alterity Therapeutics has reported Change in Accured Expenses for 6 years, with the latest figure at -$1033.6 in Q2 2020.

• For the quarter ending Q2 2020, Change in Accured Expenses fell 103.12% year-over-year to -$1033.6; the trailing twelve-month figure through Jun 2020 stood at $11459.1 (down 92.17% YoY), and the FY2020 full-year result was -$1033.6, down 103.12% from the prior year.
• Change in Accured Expenses for Q2 2020 stood at -$1033.6, up from -$48058.2 in the prior quarter.
• The five-year high for Change in Accured Expenses was $86708.3 in Q4 2017, with the low at -$48058.2 in Q4 2019.
• Average Change in Accured Expenses over 5 years is $19420.2, with a median of $13275.5 recorded in 2018.
• Peak annual rise in Change in Accured Expenses reached 4125.31% in 2019, while the deepest fall reached 275.55% in 2019.
• Tracing ATHE's Change in Accured Expenses over 5 years: stood at -$9017.2 in 2016, then surged by 1061.59% to $86708.3 in 2017, then slumped by 68.43% to $27375.1 in 2018, then sank by 275.55% to -$48058.2 in 2019, then jumped by 97.85% to -$1033.6 in 2020.
• The last three Change in Accured Expenses figures came in at -$1033.6 (Q2 2020), -$48058.2 (Q4 2019), and $33175.8 (Q2 2019), per Business Quant data.

Peer Comparison